168 related articles for article (PubMed ID: 20063032)
21. Relationship of dose of background angiotensin-converting enzyme inhibitor to the benefits of candesartan in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM)-Added trial.
McMurray JJ; Young JB; Dunlap ME; Granger CB; Hainer J; Michelson EL; Earle S; Olofsson B; Ostergren J; Yusuf S; Swedberg K; Pfeffer MA;
Am Heart J; 2006 May; 151(5):985-91. PubMed ID: 16644319
[TBL] [Abstract][Full Text] [Related]
22. Candesartan cilexetil in the treatment of chronic heart failure.
Baguet JP; Barone-Rochette G; Neuder Y
Vasc Health Risk Manag; 2009; 5(1):257-64. PubMed ID: 19436650
[TBL] [Abstract][Full Text] [Related]
23. CandeSpartan Study: Candesartan Spanish Response-prediction and Tolerability study in migraine.
García-Azorín D; Martínez-Badillo C; Camiña Muñiz J; Gago-Veiga AB; Morollón Sánchez N; González-Quintanilla V; Porta-Etessam J; Sierra-Mencía A; González-García N; González-Osorio Y; Polanco-Fernandez M; Recio-García A; Belvis Nieto R; Guerrero-Peral AL
Cephalalgia; 2024 Apr; 44(4):3331024241248833. PubMed ID: 38663908
[TBL] [Abstract][Full Text] [Related]
24. Noncholestatic acute hepatocellular injury following candesartan administration.
Lammel-Lindemann JA; Flores-Villalba E; Martagón AJ; DeObeso-Gonzalez E; Puente-Gallegos F
Br J Clin Pharmacol; 2018 Jan; 84(1):204-207. PubMed ID: 28841231
[TBL] [Abstract][Full Text] [Related]
25. A multicentre, 12-week study of imidapril and candesartan cilexetil in patients with mild to moderate hypertension using ambulatory blood pressure monitoring.
Palma-Gamiz JL; Pêgo M; Marquez E; Pujol M; Olivan J; Alegría E; Sagastagoitia-Gorostiza JD; Gonzalez-Juanatey JR
Clin Drug Investig; 2007; 27(6):407-17. PubMed ID: 17506591
[TBL] [Abstract][Full Text] [Related]
26. [Candesartan-induced cholestatic hepatitis: a case report].
Jiménez-Sáenz M; Arroyo Q; Sanjuan M; Herrerías JM
Gastroenterol Hepatol; 2010 Jan; 33(1):66-7. PubMed ID: 19713003
[No Abstract] [Full Text] [Related]
27. Angiotensin receptor antagonists.
Wong W; Howes L
Aust Fam Physician; 2000 Jul; 29(7):653-5, 658. PubMed ID: 10914449
[TBL] [Abstract][Full Text] [Related]
28. The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): a randomised, placebo-controlled, double-blind trial.
Sandset EC; Bath PM; Boysen G; Jatuzis D; Kõrv J; Lüders S; Murray GD; Richter PS; Roine RO; Terént A; Thijs V; Berge E;
Lancet; 2011 Feb; 377(9767):741-50. PubMed ID: 21316752
[TBL] [Abstract][Full Text] [Related]
29. [Role of antihypertensive drugs in the treatment of migraine].
Fehér G; Pusch G
Orv Hetil; 2015 Feb; 156(5):179-85. PubMed ID: 25618859
[TBL] [Abstract][Full Text] [Related]
30. Angiotensin receptor blocker therapy for heart failure patients: is combination treatment a feasible prospect?
Mehta PA; McDonagh S; Phillips J; Grocott-Mason R; Dubrey SW
Clin Cardiol; 2009 Sep; 32(9):513-8. PubMed ID: 19743497
[TBL] [Abstract][Full Text] [Related]
31. Effects of candesartan cilexetil and enalapril on inflammatory markers of atherosclerosis in hypertensive patients with non-insulin-dependent diabetes mellitus.
Rosei EA; Rizzoni D; Muiesan ML; Sleiman I; Salvetti M; Monteduro C; Porteri E;
J Hypertens; 2005 Feb; 23(2):435-44. PubMed ID: 15662233
[TBL] [Abstract][Full Text] [Related]
32. [Ace inhibitors and angiotensin II receptor antagonists for therapy of chronic heart failure].
Kuwabara Y; Komuro I
Nihon Naika Gakkai Zasshi; 2005 Feb; 94(2):255-61. PubMed ID: 15768589
[No Abstract] [Full Text] [Related]
33. Warnings against candesartan in pregnancy are not implemented in physicians' practice.
Borthen C; Oglaend B; Eggebøe T; Ellingsen CL; Schjøtt J
Eur J Obstet Gynecol Reprod Biol; 2009 Oct; 146(2):235. PubMed ID: 19615811
[No Abstract] [Full Text] [Related]
34. Comparison of selective AT1-receptor blockade versus ACE inhibition for restenosis prophylaxis in patients with peripheral occlusive arterial disease after stent angioplasty: a randomized, controlled, proof-of-concept study.
Schindler C; Mueller A; Bramlage P; Boecking W; Kirch W; Schweizer J
Angiology; 2007 Dec-2008 Jan; 58(6):710-6. PubMed ID: 17928625
[TBL] [Abstract][Full Text] [Related]
35. Efficacy of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in the Preventative Treatment of Episodic Migraine in Adults.
Dorosch T; Ganzer CA; Lin M; Seifan A
Curr Pain Headache Rep; 2019 Sep; 23(11):85. PubMed ID: 31515634
[TBL] [Abstract][Full Text] [Related]
36. Use of angiotensin receptor blockers after angioedema with an angiotensin-converting enzyme inhibitor.
Haymore BR; DeZee KJ
Ann Allergy Asthma Immunol; 2009 Jul; 103(1):83-4. PubMed ID: 19663135
[No Abstract] [Full Text] [Related]
37. Angiotensin-II-receptor inhibitors in pregnancy.
Hinsberger A; Wingen AM; Hoyer PF
Lancet; 2001 May; 357(9268):1620. PubMed ID: 11386315
[No Abstract] [Full Text] [Related]
38. Differential clinical profile of candesartan compared to other angiotensin receptor blockers.
Cernes R; Mashavi M; Zimlichman R
Vasc Health Risk Manag; 2011; 7():749-59. PubMed ID: 22241949
[TBL] [Abstract][Full Text] [Related]
39. Rash and acute nephritic syndrome due to candesartan.
Morton A; Muir J; Lim D
BMJ; 2004 Jan; 328(7430):25. PubMed ID: 14703542
[No Abstract] [Full Text] [Related]
40. Concomitant administration of candesartan cilexetil in patients on paclitaxel and carboplatin combination therapy increases risk of severe neutropenia
.
Katsube Y; Hira D; Tsujimoto M; Koide H; Minegaki T; Ikeda Y; Morita SY; Nishiguchi K; Terada T
Int J Clin Pharmacol Ther; 2018 Jul; 56(7):328-336. PubMed ID: 29792394
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
